S&P500 and Nasdaq 100: US Stocks Steady as Traders Await Powell's Fed Outlook

U.S. equities edged higher Wednesday as investors awaited the Federal Reserve's interest rate decision amid escalating Middle East tensions. While major indexes traded cautiously near recent peaks, geopolitical uncertainty capped risk appetite. The Fed is expected to hold rates steady, with markets closely monitoring Chair Powell's commentary for signals on inflation and potential rate cuts, as sticky inflation and global conflict complicate the economic outlook. AI-related stocks and select companies such as Nucor, which issued a strong profit outlook, outperformed, but overall market gains were tempered by uncertainty ahead of the Fed announcement and upcoming economic data.

Analysis

U.S. equities demonstrated cautious upward movement as market participants anticipated the Federal Reserve's interest rate decision, while simultaneously monitoring escalating geopolitical tensions in the Middle East, which have capped broader risk appetite. The S&P 500 and Nasdaq, trading 2.5% and 3.3% below their respective all-time highs, reflect this hesitancy despite rallying through May. The Federal Reserve is widely expected to maintain current interest rates, with Fed funds futures indicating market expectations of approximately 46 basis points in rate cuts by year-end and a 55% probability of a quarter-point reduction in September. However, persistent inflation, highlighted by Goldman Sachs' Simon Dangoor's warning of potential tariff-induced income shocks, and global conflicts complicate the monetary policy outlook, even as initial jobless claims, though recently dipped, remain elevated, suggesting a gradual cooling in the labor market. Sector-wise, Energy and Consumer Discretionary led with 0.6% gains, while Healthcare lagged, declining 0.4%. Specific equities showed notable strength: Marvell Technology (MRVL) advanced 8.7% to a three-month high, Nucor (NUE) climbed 4.9% following a positive Q2 profit outlook, and Scholar Rock (SRRK) surged 17.4% on promising drug trial results involving an Eli Lilly (LLY) treatment. The market's cautious sentiment, reflected by a "mixed" general sentiment score of 0.15, is further underscored by a modest number of new 52-week highs relative to lows, indicating investors are awaiting further clarity from the Fed and upcoming economic data, particularly the PCE inflation report.

Key Decisions for Investors

• Closely monitor Federal Reserve Chair Jerome Powell's commentary for nuances regarding inflation control and the potential timing of rate cuts, as market expectations for roughly 46 basis points of easing by year-end are a key sensitivity.
• Factor in heightened geopolitical risk, especially concerning potential U.S. involvement in Middle East conflicts, which could significantly dampen risk appetite and impact asset prices, irrespective of Fed policy.
• Focus on upcoming key economic indicators, such as the PCE inflation report and consumer sentiment data, as these will heavily influence the Fed's policy trajectory and market direction in the near term.
• Consider selective exposure to fundamentally strong companies or outperforming segments like AI-related stocks (e.g., MRVL with a +0.7 sentiment) and specific industrials (e.g., NUE with +0.7 sentiment) that have demonstrated resilience and positive catalysts amidst broader market caution.